Eisai Key Executives
This section highlights Eisai 's key executives, including their titles and compensation details.
Find Contacts at Eisai
(Showing 0 of )
Eisai Earnings
This section highlights Eisai 's earnings, including key dates, EPS, earnings reports, and earnings call transcripts.
Next Earnings Date
Date:
May 12, 2025
Time:
Before Market
Est. EPS:
$-
Status:
Unconfirmed
Last Earnings Results
Date:
February 06, 2025
EPS:
$84.31
Est. EPS:
$41.71
Revenue:
$216.14B
Earnings Call Transcripts
| Transcript | Quarter | Year | Date | Estimated EPS | Actual EPS |
|---|---|---|---|---|---|
| Read Transcript | Q3 | 2024 | 2025-02-08 | N/A | N/A |
| Read Transcript | Q2 | 2024 | 2024-11-09 | N/A | N/A |
| Read Transcript | Q1 | 2024 | 2024-08-02 | $24.46 | $36.95 |
| Read Transcript | Q4 | 2023 | 2024-05-15 | $41.10 | $46.40 |
| Read Transcript | Q3 | 2023 | 2023-02-06 | $29.76 | $30.14 |
| Read Transcript | Q2 | 2023 | 2022-11-07 | $27.11 | $12.44 |
| Read Transcript | Q1 | 2023 | 2022-08-06 | N/A | N/A |
Eisai Co., Ltd. offers pharmaceutical products in Japan. It offers Aricept for the treatment of alzheimer's disease/dementia with Lewy bodies; Methycobal for the treatment of peripheral neuropathy; and Fycompa, an antiepileptic drug for the adjunctive treatment of partial-onset and primary generalized tonic-clonic seizures. The company also provides Lyrica for pain treatment; Dayvigo, an anti-insomnia drug for the treatment of adults with insomnia; Lenvima, an anticancer agent/molecular targeted medicine for the treatment of thyroid cancer, renal cell carcinoma in combination with everolimus, and hepatocellular carcinoma; and Halaven, an anticancer agent/microtubule dynamics inhibitor for the treatment of breast cancer and liposarcoma. In addition, it offers Pariet, a proton-pump inhibitor for the treatment of gastric and duodenal ulcers, reflux esophagitis, and eradication of Helicobacter pylori infections, etc.; Humira, a fully human anti-TNF-a monoclonal antibody for the treatment of autoimmune diseases, such as rheumatoid arthritis; and Chocola BB plus, a vitamin B2 preparation for rough skin and stomatitis, as well as various products, which include third-class OTC drugs, designated quasi-drugs, and food with nutrient function. The company was formerly known as Nihon Eisai Co., Ltd. and changed its name to Eisai Co., Ltd. in 1955. Eisai Co., Ltd. was incorporated in 1941 and is headquartered in Tokyo, Japan.
Healthcare
Drug Manufacturers - Specialty & Generic
$4321.00
Stock Price
$1.22T
Market Cap
-
Employees
Tokyo, None
Location
Financial Statements
Access annual & quarterly financial statements for Eisai , including income statements, balance sheets, and cash flow statements..
Annual Income Statement
| Breakdown | March 31, 2024 | March 31, 2023 | March 31, 2022 | March 31, 2021 | March 31, 2020 |
|---|---|---|---|---|---|
| Revenue | $741.75B | $744.40B | $756.23B | $645.94B | $695.62B |
| Cost of Revenue | $155.33B | $177.84B | $174.83B | $161.31B | $175.69B |
| Gross Profit | $586.42B | $566.57B | $581.39B | $484.63B | $519.93B |
| Gross Profit Ratio | 79.06% | 76.11% | 76.90% | 75.03% | 74.74% |
| Research and Development Expenses | $169.02B | $173.00B | $171.74B | $150.30B | $140.12B |
| General and Administrative Expenses | $374.42B | $358.29B | $366.43B | $281.40B | $256.30B |
| Selling and Marketing Expenses | $-10.34B | $- | $- | $- | $- |
| Selling General and Administrative Expenses | $364.08B | $358.29B | $366.43B | $281.40B | $256.30B |
| Other Expenses | $- | $- | $-10.52B | $1.17B | $-1.99B |
| Operating Expenses | $533.01B | $526.53B | $527.64B | $432.87B | $394.43B |
| Cost and Expenses | $688.34B | $704.36B | $702.48B | $594.18B | $570.12B |
| Interest Income | $10.80B | $7.24B | $2.40B | $2.15B | $4.02B |
| Interest Expense | $2.39B | $2.27B | $1.69B | $1.36B | $1.46B |
| Depreciation and Amortization | $39.40B | $39.98B | $38.40B | $36.30B | $33.70B |
| EBITDA | $103.11B | $87.26B | $94.55B | $90.05B | $162.94B |
| EBITDA Ratio | 13.90% | 11.72% | 12.50% | 13.97% | 23.46% |
| Operating Income | $53.41B | $40.04B | $53.75B | $51.77B | $125.50B |
| Operating Income Ratio | 7.20% | 5.38% | 7.11% | 8.01% | 18.04% |
| Total Other Income Expenses Net | $8.41B | $4.97B | $708.00M | $-668.00M | $2.56B |
| Income Before Tax | $61.82B | $45.01B | $54.46B | $52.55B | $128.06B |
| Income Before Tax Ratio | 8.33% | 6.05% | 7.20% | 8.14% | 18.41% |
| Income Tax Expense | $18.04B | $-11.82B | $8.74B | $10.07B | $5.60B |
| Net Income | $42.41B | $55.43B | $47.95B | $41.94B | $121.77B |
| Net Income Ratio | 5.72% | 7.45% | 6.34% | 6.49% | 17.50% |
| EPS | $147.86 | $193.31 | $167.27 | $146.95 | $425.01 |
| EPS Diluted | $147.86 | $193.30 | $167.25 | $146.90 | $424.80 |
| Weighted Average Shares Outstanding | 286.80M | 286.76M | 286.69M | 286.62M | 286.51M |
| Weighted Average Shares Outstanding Diluted | 286.80M | 286.76M | 286.73M | 286.71M | 286.65M |
| SEC Filing | Source | Source | Source | Source | Source |
| Breakdown | December 31, 2024 | September 30, 2024 | June 30, 2024 | March 31, 2024 | December 31, 2023 | September 30, 2023 | June 30, 2023 | March 31, 2023 | December 31, 2022 | September 30, 2022 | June 30, 2022 | March 31, 2022 | December 31, 2021 | September 30, 2021 | June 30, 2021 | March 31, 2021 | December 31, 2020 | September 30, 2020 | June 30, 2020 | March 31, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $216.14B | $195.99B | $189.03B | $190.50B | $177.70B | $176.62B | $196.94B | $198.21B | $187.57B | $174.36B | $184.26B | $190.90B | $202.97B | $163.46B | $198.89B | $147.61B | $181.29B | $151.46B | $165.58B | $209.56B |
| Cost of Revenue | $45.94B | $42.51B | $39.76B | $36.11B | $38.88B | $36.43B | $43.92B | $38.56B | $46.73B | $45.13B | $47.40B | $50.74B | $44.22B | $40.62B | $39.25B | $41.15B | $40.45B | $41.43B | $38.28B | $48.51B |
| Gross Profit | $170.21B | $153.48B | $149.27B | $154.39B | $138.82B | $140.19B | $153.01B | $159.64B | $140.84B | $129.23B | $136.86B | $140.16B | $158.75B | $122.84B | $159.64B | $106.46B | $140.84B | $110.03B | $127.30B | $161.05B |
| Gross Profit Ratio | 78.75% | 78.31% | 78.97% | 81.00% | 78.10% | 79.40% | 77.70% | 80.50% | 75.10% | 74.10% | 74.30% | 73.40% | 78.20% | 75.10% | 80.30% | 72.12% | 77.69% | 72.65% | 76.88% | 76.85% |
| Research and Development Expenses | $43.56B | $40.03B | $41.74B | $44.55B | $41.70B | $41.63B | $41.15B | $51.60B | $39.89B | $43.02B | $38.50B | $48.45B | $43.36B | $38.12B | $41.81B | $42.12B | $40.64B | $37.00B | $30.53B | $37.07B |
| General and Administrative Expenses | $- | $- | $- | $103.38B | $92.17B | $92.79B | $86.08B | $85.32B | $92.58B | $88.08B | $92.31B | $110.49B | $101.46B | $79.76B | $74.72B | $70.04B | $77.46B | $68.97B | $64.92B | $67.86B |
| Selling and Marketing Expenses | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Selling General and Administrative Expenses | $104.52B | $97.42B | $99.54B | $103.38B | $92.17B | $92.79B | $86.08B | $85.32B | $92.58B | $88.08B | $92.31B | $110.49B | $101.46B | $79.76B | $74.72B | $70.04B | $77.46B | $68.97B | $64.92B | $67.86B |
| Other Expenses | $-5.43B | $5.42B | $-5.42B | $- | $- | $- | $- | $- | $- | $- | $-1.38B | $2.04B | $282.00M | $-536.00M | $-12.30B | $225.00M | $-878.00M | $2.10B | $-273.00M | $3.95B |
| Operating Expenses | $142.64B | $142.86B | $135.87B | $147.93B | $132.71B | $134.79B | $126.99B | $133.42B | $132.27B | $131.41B | $129.42B | $160.97B | $145.10B | $117.34B | $104.24B | $112.39B | $117.23B | $108.07B | $95.18B | $108.88B |
| Cost and Expenses | $188.58B | $185.37B | $175.62B | $184.03B | $171.59B | $171.22B | $170.91B | $171.99B | $179.00B | $176.54B | $176.83B | $211.71B | $189.32B | $157.96B | $143.49B | $153.53B | $157.68B | $149.50B | $133.46B | $157.39B |
| Interest Income | $- | $- | $3.28B | $3.11B | $2.33B | $2.58B | $2.79B | $2.00B | $1.50B | $1.04B | $2.69B | $534.00M | $648.00M | $470.00M | $749.00M | $551.00M | $613.00M | $330.00M | $651.00M | $644.00M |
| Interest Expense | $- | $- | $715.00M | $845.00M | $403.00M | $610.00M | $530.00M | $793.00M | $618.00M | $448.00M | $407.00M | $509.00M | $405.00M | $404.00M | $374.00M | $432.00M | $301.00M | $305.00M | $323.00M | $555.00M |
| Depreciation and Amortization | $10.04B | $9.97B | $10.06B | $9.98B | $9.89B | $9.77B | $9.76B | $10.13B | $10.15B | $9.89B | $9.80B | $9.21B | $9.89B | $9.85B | $9.46B | $9.47B | $9.17B | $8.98B | $8.68B | $8.57B |
| EBITDA | $41.34B | $24.40B | $26.75B | $28.96B | $18.33B | $17.75B | $38.57B | $38.35B | $20.23B | $8.75B | $19.93B | $-11.07B | $24.19B | $15.82B | $65.61B | $4.09B | $33.39B | $11.27B | $41.45B | $61.38B |
| EBITDA Ratio | 19.13% | 12.45% | 14.15% | 8.63% | 10.31% | 10.05% | 19.59% | 19.35% | 10.78% | 5.02% | 10.82% | -5.80% | 11.92% | 9.68% | 32.99% | 2.77% | 18.42% | 7.44% | 25.03% | 29.29% |
| Operating Income | $27.57B | $10.62B | $13.41B | $6.46B | $6.11B | $5.40B | $26.03B | $26.22B | $8.57B | $-2.18B | $7.43B | $-20.80B | $13.65B | $5.50B | $55.41B | $-5.92B | $23.61B | $1.96B | $32.12B | $52.16B |
| Operating Income Ratio | 12.75% | 5.42% | 7.09% | 3.39% | 3.44% | 3.06% | 13.22% | 13.23% | 4.57% | -1.25% | 4.03% | -10.90% | 6.72% | 3.36% | 27.86% | -4.01% | 13.02% | 1.29% | 19.40% | 24.89% |
| Total Other Income Expenses Net | $1.99B | $4.94B | $2.56B | $2.26B | $1.92B | $1.97B | $2.26B | $1.21B | $886.00M | $594.00M | $2.29B | $24.00M | $263.00M | $65.00M | $376.00M | $-1.33B | $312.00M | $25.00M | $328.00M | $90.00M |
| Income Before Tax | $29.55B | $15.57B | $15.97B | $18.13B | $8.03B | $7.37B | $28.29B | $27.42B | $9.46B | $-1.59B | $9.72B | $-20.78B | $13.89B | $5.56B | $55.78B | $-5.80B | $23.92B | $1.98B | $32.45B | $52.25B |
| Income Before Tax Ratio | 13.67% | 7.94% | 8.45% | 9.52% | 4.52% | 4.17% | 14.36% | 13.84% | 5.04% | -0.91% | 5.28% | -10.88% | 6.84% | 3.40% | 28.05% | -3.93% | 13.20% | 1.31% | 19.60% | 24.94% |
| Income Tax Expense | $5.16B | $4.01B | $4.46B | $5.15B | $1.40B | $4.10B | $7.38B | $11.51B | $333.00M | $-5.42B | $-18.25B | $-6.91B | $844.00M | $1.33B | $13.48B | $-2.44B | $4.19B | $613.00M | $7.70B | $3.67B |
| Net Income | $23.79B | $11.11B | $10.58B | $13.31B | $5.97B | $2.79B | $20.34B | $16.32B | $8.64B | $3.57B | $26.90B | $-12.40B | $14.17B | $4.02B | $42.16B | $-3.05B | $19.37B | $1.37B | $24.43B | $48.52B |
| Net Income Ratio | 11.01% | 5.67% | 5.60% | 6.99% | 3.36% | 1.58% | 10.33% | 8.24% | 4.61% | 2.05% | 14.60% | -6.50% | 6.98% | 2.46% | 21.20% | -2.06% | 10.68% | 0.91% | 14.75% | 23.15% |
| EPS | $84.31 | $39.19 | $36.95 | $46.36 | $20.81 | $9.73 | $70.92 | $56.89 | $30.14 | $49.77 | $93.82 | $-43.27 | $197.56 | $54.88 | $147.07 | $-10.64 | $270.32 | $19.16 | $340.92 | $169.41 |
| EPS Diluted | $84.31 | $39.19 | $36.95 | $46.36 | $20.81 | $9.73 | $70.92 | $56.89 | $30.14 | $49.77 | $93.79 | $-43.26 | $197.52 | $54.88 | $147.07 | $-10.64 | $270.24 | $19.12 | $340.80 | $169.41 |
| Weighted Average Shares Outstanding | 282.19M | 283.53M | 286.35M | 287.04M | 286.81M | 286.81M | 286.80M | 286.90M | 286.80M | 286.80M | 286.71M | 286.69M | 286.67M | 286.80M | 286.67M | 286.50M | 286.80M | 286.80M | 286.80M | 286.39M |
| Weighted Average Shares Outstanding Diluted | 282.19M | 283.53M | 286.35M | 287.04M | 286.81M | 286.81M | 286.80M | 286.90M | 286.80M | 286.80M | 286.80M | 286.70M | 286.67M | 286.80M | 286.67M | 286.50M | 286.80M | 286.80M | 286.80M | 286.39M |
| SEC Filing | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source |
Annual Balance Sheet
| Breakdown | March 31, 2024 | March 31, 2023 | March 31, 2022 | March 31, 2021 | March 31, 2020 |
|---|---|---|---|---|---|
| Cash and Cash Equivalents | $304.68B | $267.35B | $309.63B | $248.74B | $254.24B |
| Short Term Investments | $445.00M | $540.00M | $432.00M | $267.00M | $1.55B |
| Cash and Short Term Investments | $305.12B | $267.89B | $310.06B | $249.01B | $255.80B |
| Net Receivables | $217.21B | $187.26B | $207.95B | $160.31B | $180.02B |
| Inventory | $174.65B | $140.42B | $99.01B | $85.12B | $65.73B |
| Other Current Assets | $26.00B | $26.64B | $23.58B | $23.91B | $19.85B |
| Total Current Assets | $722.98B | $622.20B | $640.61B | $518.34B | $521.40B |
| Property Plant Equipment Net | $164.89B | $166.63B | $169.93B | $160.93B | $144.64B |
| Goodwill | $236.37B | $208.82B | $191.76B | $171.78B | $168.68B |
| Intangible Assets | $85.49B | $89.23B | $95.45B | $108.64B | $106.09B |
| Goodwill and Intangible Assets | $321.86B | $298.05B | $287.21B | $280.42B | $274.78B |
| Long Term Investments | $58.42B | $73.88B | $64.95B | $63.38B | $54.88B |
| Tax Assets | $100.83B | $102.59B | $76.62B | $66.92B | $66.44B |
| Other Non-Current Assets | $24.82B | $1.00M | $- | $1.00M | $- |
| Total Non-Current Assets | $670.82B | $641.15B | $598.71B | $571.66B | $540.74B |
| Other Assets | $- | $- | $- | $- | $- |
| Total Assets | $1.39T | $1.26T | $1.24T | $1.09T | $1.06T |
| Account Payables | $23.96B | $86.83B | $108.06B | $94.55B | $76.88B |
| Short Term Debt | $34.24B | $41.20B | $- | $39.98B | $34.99B |
| Tax Payables | $8.72B | $2.22B | $6.88B | $2.52B | $5.36B |
| Deferred Revenue | $- | $59.88B | $-9.95B | $37.36B | $49.60B |
| Other Current Liabilities | $237.56B | $168.69B | $198.39B | $118.96B | $134.74B |
| Total Current Liabilities | $304.47B | $298.94B | $313.33B | $256.02B | $251.97B |
| Long Term Debt | $134.77B | $82.49B | $94.89B | $50.07B | $54.95B |
| Deferred Revenue Non-Current | $- | $38.29B | $40.69B | $41.21B | $37.92B |
| Deferred Tax Liabilities Non-Current | $704.00M | $664.00M | $483.00M | $511.00M | $569.00M |
| Other Non-Current Liabilities | $54.88B | $17.98B | $18.39B | $14.42B | $14.11B |
| Total Non-Current Liabilities | $190.35B | $141.83B | $154.45B | $106.05B | $107.55B |
| Other Liabilities | $- | $- | $- | $- | $- |
| Total Liabilities | $494.82B | $440.78B | $467.78B | $362.07B | $359.51B |
| Preferred Stock | $- | $612.93B | $595.24B | $596.54B | $593.62B |
| Common Stock | $44.99B | $44.99B | $44.99B | $44.99B | $44.99B |
| Retained Earnings | $526.49B | $522.77B | $506.58B | $507.98B | $505.36B |
| Accumulated Other Comprehensive Income Loss | $258.89B | $187.03B | $153.58B | $106.64B | $84.51B |
| Other Total Stockholders Equity | $45.25B | $45.17B | $43.67B | $43.58B | $43.27B |
| Total Stockholders Equity | $875.61B | $799.96B | $748.82B | $703.18B | $678.13B |
| Total Equity | $898.98B | $822.57B | $771.53B | $727.94B | $702.63B |
| Total Liabilities and Stockholders Equity | $1.39T | $1.26T | $1.24T | $1.09T | $1.06T |
| Minority Interest | $23.36B | $22.61B | $22.71B | $24.76B | $24.50B |
| Total Liabilities and Total Equity | $1.39T | $1.26T | $1.24T | $1.09T | $1.06T |
| Total Investments | $57.67B | $52.46B | $44.03B | $43.82B | $39.78B |
| Total Debt | $159.41B | $126.11B | $94.89B | $89.89B | $89.94B |
| Net Debt | $-145.27B | $-141.25B | $-214.74B | $-158.85B | $-164.31B |
Balance Sheet Charts
| Breakdown | December 31, 2024 | September 30, 2024 | June 30, 2024 | March 31, 2024 | December 31, 2023 | September 30, 2023 | June 30, 2023 | March 31, 2023 | December 31, 2022 | September 30, 2022 | June 30, 2022 | March 31, 2022 | December 31, 2021 | September 30, 2021 | June 30, 2021 | March 31, 2021 | December 31, 2020 | September 30, 2020 | June 30, 2020 | March 31, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and Cash Equivalents | $291.26B | $268.61B | $303.94B | $304.68B | $284.79B | $281.45B | $269.31B | $267.35B | $268.00B | $264.53B | $287.81B | $309.63B | $258.42B | $283.00B | $213.08B | $248.74B | $193.78B | $228.02B | $226.31B | $254.24B |
| Short Term Investments | $- | $- | $- | $445.00M | $401.00M | $501.00M | $1.81B | $540.00M | $983.00M | $1.00B | $2.64B | $432.00M | $921.00M | $722.00M | $492.00M | $267.00M | $656.00M | $947.00M | $666.00M | $1.55B |
| Cash and Short Term Investments | $291.26B | $268.61B | $303.94B | $304.68B | $285.19B | $281.95B | $271.12B | $267.89B | $268.99B | $265.53B | $290.45B | $310.06B | $259.34B | $283.72B | $213.57B | $249.01B | $194.44B | $228.97B | $226.97B | $255.80B |
| Net Receivables | $235.64B | $195.22B | $205.35B | $217.21B | $186.18B | $191.91B | $189.21B | $187.26B | $189.00B | $178.09B | $198.94B | $207.95B | $214.60B | $174.61B | $236.34B | $160.31B | $201.98B | $183.03B | $183.99B | $180.02B |
| Inventory | $206.11B | $192.09B | $190.60B | $174.65B | $163.25B | $159.97B | $149.94B | $140.42B | $120.86B | $114.41B | $103.51B | $99.01B | $92.51B | $90.04B | $89.85B | $85.12B | $78.95B | $74.93B | $70.92B | $65.73B |
| Other Current Assets | $28.09B | $25.99B | $33.33B | $25.70B | $26.38B | $25.43B | $29.82B | $26.64B | $31.27B | $27.35B | $28.04B | $23.58B | $20.61B | $22.34B | $22.75B | $23.91B | $20.26B | $17.60B | $19.36B | $19.85B |
| Total Current Assets | $761.10B | $681.91B | $733.22B | $722.24B | $661.00B | $659.27B | $640.07B | $622.20B | $610.12B | $585.38B | $620.95B | $640.61B | $587.06B | $570.72B | $562.51B | $518.34B | $495.62B | $504.52B | $501.25B | $521.40B |
| Property Plant Equipment Net | $159.93B | $157.27B | $165.35B | $164.89B | $159.94B | $165.29B | $166.00B | $166.63B | $165.16B | $175.69B | $172.90B | $169.93B | $162.41B | $159.35B | $159.07B | $160.93B | $143.48B | $143.10B | $144.31B | $144.64B |
| Goodwill | $246.84B | $223.04B | $251.32B | $236.37B | $221.58B | $233.51B | $226.42B | $208.82B | $207.49B | $226.21B | $213.78B | $191.76B | $178.56B | $173.70B | $171.62B | $171.78B | $160.62B | $164.08B | $167.00B | $168.68B |
| Intangible Assets | $79.16B | $77.78B | $82.97B | $85.49B | $86.23B | $86.03B | $87.56B | $89.23B | $89.11B | $93.77B | $93.92B | $95.45B | $105.31B | $107.78B | $110.89B | $108.64B | $107.50B | $109.81B | $103.45B | $106.09B |
| Goodwill and Intangible Assets | $326.00B | $300.82B | $334.29B | $321.86B | $307.81B | $319.55B | $313.97B | $298.05B | $296.60B | $319.98B | $307.69B | $287.21B | $283.87B | $281.48B | $282.51B | $280.42B | $268.12B | $273.89B | $270.46B | $274.78B |
| Long Term Investments | $- | $84.14B | $59.62B | $58.42B | $58.15B | $62.59B | $82.61B | $51.92B | $44.88B | $47.20B | $69.93B | $64.95B | $61.21B | $62.39B | $39.98B | $43.55B | $41.15B | $41.98B | $41.64B | $38.22B |
| Tax Assets | $- | $- | $101.89B | $100.83B | $102.41B | $105.87B | $102.43B | $102.59B | $112.91B | $111.49B | $101.39B | $76.62B | $72.81B | $66.17B | $65.51B | $66.92B | $65.19B | $67.98B | $67.63B | $66.44B |
| Other Non-Current Assets | $185.83B | $97.28B | $25.87B | $25.56B | $21.92B | $21.43B | $1.00M | $21.95B | $21.40B | $21.55B | $- | $- | $-1.00M | $1.00M | $19.76B | $19.84B | $15.00B | $15.14B | $15.02B | $16.66B |
| Total Non-Current Assets | $671.76B | $639.51B | $687.02B | $671.56B | $650.24B | $674.72B | $665.02B | $641.15B | $640.95B | $675.90B | $651.92B | $598.71B | $580.30B | $569.39B | $566.83B | $571.66B | $532.94B | $542.10B | $539.05B | $540.74B |
| Other Assets | $- | $- | $- | $- | $- | $1.00M | $-1.00M | $- | $- | $-1.00M | $- | $- | $- | $- | $1.00M | $- | $- | $- | $- | $- |
| Total Assets | $1.43T | $1.32T | $1.42T | $1.39T | $1.31T | $1.33T | $1.31T | $1.26T | $1.25T | $1.26T | $1.27T | $1.24T | $1.17T | $1.14T | $1.13T | $1.09T | $1.03T | $1.05T | $1.04T | $1.06T |
| Account Payables | $64.53B | $66.32B | $77.80B | $23.96B | $56.06B | $61.09B | $61.43B | $86.83B | $68.87B | $76.83B | $96.11B | $108.06B | $90.64B | $76.28B | $80.78B | $94.55B | $70.19B | $77.90B | $61.87B | $76.88B |
| Short Term Debt | $119.28B | $83.08B | $47.55B | $34.24B | $31.50B | $48.30B | $51.30B | $41.20B | $65.20B | $10.00B | $10.00B | $- | $40.00B | $39.99B | $42.77B | $39.98B | $- | $- | $35.00B | $34.99B |
| Tax Payables | $- | $- | $6.05B | $8.72B | $6.48B | $8.17B | $6.64B | $2.22B | $6.89B | $5.46B | $9.03B | $6.88B | $14.37B | $12.02B | $9.52B | $2.52B | $3.49B | $5.46B | $6.31B | $5.36B |
| Deferred Revenue | $- | $- | $- | $8.72B | $71.65B | $72.59B | $69.34B | $59.88B | $70.47B | $71.40B | $73.29B | $-9.95B | $70.63B | $66.55B | $64.83B | $37.36B | $- | $- | $45.41B | $49.60B |
| Other Current Liabilities | $197.81B | $177.43B | $179.62B | $237.56B | $183.74B | $189.74B | $176.50B | $168.69B | $172.71B | $174.25B | $186.76B | $198.39B | $159.99B | $152.54B | $144.87B | $118.96B | $117.75B | $119.87B | $128.34B | $134.74B |
| Total Current Liabilities | $381.62B | $326.84B | $311.02B | $304.47B | $277.78B | $307.31B | $295.87B | $298.94B | $313.68B | $266.54B | $301.89B | $313.33B | $304.99B | $280.83B | $277.93B | $256.02B | $191.43B | $203.23B | $231.52B | $251.97B |
| Long Term Debt | $99.82B | $99.81B | $134.79B | $172.51B | $134.76B | $44.74B | $44.80B | $82.49B | $48.30B | $44.27B | $45.05B | $94.89B | $49.92B | $49.92B | $9.60B | $50.07B | $89.88B | $89.88B | $54.95B | $54.95B |
| Deferred Revenue Non-Current | $- | $- | $- | $37.73B | $38.69B | $40.18B | $40.12B | $38.29B | $36.62B | $40.64B | $39.86B | $40.69B | $38.10B | $39.19B | $40.32B | $41.21B | $35.60B | $36.54B | $36.97B | $37.92B |
| Deferred Tax Liabilities Non-Current | $- | $- | $801.00M | $704.00M | $489.00M | $480.00M | $768.00M | $664.00M | $1.22B | $1.00B | $730.00M | $483.00M | $316.00M | $531.00M | $276.00M | $511.00M | $490.00M | $453.00M | $298.00M | $569.00M |
| Other Non-Current Liabilities | $53.16B | $50.44B | $53.95B | $-20.59B | $16.80B | $16.26B | $15.77B | $17.98B | $17.56B | $17.48B | $17.13B | $18.39B | $15.35B | $14.30B | $13.55B | $14.42B | $13.95B | $13.70B | $13.24B | $14.11B |
| Total Non-Current Liabilities | $152.99B | $150.26B | $189.53B | $190.35B | $190.74B | $141.84B | $141.56B | $141.83B | $140.32B | $144.04B | $142.63B | $154.45B | $103.69B | $103.94B | $104.05B | $106.05B | $139.93B | $140.56B | $105.47B | $107.55B |
| Other Liabilities | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Total Liabilities | $534.60B | $477.10B | $500.55B | $494.82B | $468.52B | $449.15B | $437.43B | $440.78B | $454.00B | $410.57B | $444.52B | $467.78B | $408.69B | $384.77B | $381.99B | $362.07B | $331.36B | $343.79B | $336.99B | $359.51B |
| Preferred Stock | $- | $- | $- | $- | $- | $- | $613.83B | $- | $- | $- | $602.00B | $595.24B | $609.67B | $619.84B | $- | $- | $- | $- | $- | $- |
| Common Stock | $44.99B | $44.99B | $44.99B | $44.99B | $44.99B | $44.99B | $44.99B | $44.99B | $44.99B | $44.99B | $44.99B | $44.99B | $44.99B | $44.99B | $44.99B | $44.99B | $44.99B | $44.99B | $44.99B | $44.99B |
| Retained Earnings | $509.72B | $526.09B | $514.23B | $526.49B | $507.73B | $526.66B | $523.63B | $522.77B | $504.95B | $518.19B | $513.31B | $506.58B | $521.07B | $531.21B | $526.03B | $507.98B | $505.64B | $509.58B | $507.96B | $505.36B |
| Accumulated Other Comprehensive Income Loss | $285.28B | $232.93B | $299.87B | $258.89B | $220.92B | $244.76B | $231.03B | $187.03B | $178.92B | $219.77B | $202.54B | $153.58B | $125.12B | $110.50B | $107.93B | $88.56B | $78.11B | $80.17B | $82.36B | $84.51B |
| Other Total Stockholders Equity | $33.37B | $16.06B | $36.68B | $45.25B | $45.26B | $45.26B | $45.22B | $45.17B | $45.18B | $45.19B | $43.70B | $43.67B | $43.62B | $43.64B | $43.60B | $43.58B | $43.44B | $43.47B | $43.34B | $43.27B |
| Total Stockholders Equity | $873.36B | $820.06B | $895.77B | $875.61B | $818.89B | $861.67B | $844.87B | $799.96B | $774.03B | $828.13B | $804.54B | $748.82B | $734.79B | $730.34B | $722.55B | $703.18B | $672.18B | $678.20B | $678.65B | $678.13B |
| Total Equity | $898.26B | $844.32B | $919.70B | $898.98B | $842.72B | $884.85B | $867.66B | $822.57B | $797.07B | $850.70B | $828.35B | $771.53B | $758.67B | $755.34B | $747.35B | $727.94B | $697.20B | $702.83B | $703.31B | $702.63B |
| Total Liabilities and Stockholders Equity | $1.43T | $1.32T | $1.42T | $1.39T | $1.31T | $1.33T | $1.31T | $1.26T | $1.25T | $1.26T | $1.27T | $1.24T | $1.17T | $1.14T | $1.13T | $1.09T | $1.03T | $1.05T | $1.04T | $1.06T |
| Minority Interest | $24.90B | $24.26B | $23.93B | $23.36B | $23.82B | $23.18B | $22.79B | $22.61B | $23.04B | $22.58B | $23.80B | $22.71B | $23.88B | $25.00B | $24.80B | $24.76B | $25.02B | $24.62B | $24.66B | $24.50B |
| Total Liabilities and Total Equity | $1.43T | $1.32T | $1.42T | $1.39T | $1.31T | $1.33T | $1.31T | $1.26T | $1.25T | $1.26T | $1.27T | $1.24T | $1.17T | $1.14T | $1.13T | $1.09T | $1.03T | $1.05T | $1.04T | $1.06T |
| Total Investments | $- | $84.14B | $59.62B | $58.42B | $58.55B | $63.09B | $61.56B | $52.46B | $45.87B | $48.20B | $49.21B | $44.03B | $41.97B | $43.10B | $40.47B | $43.82B | $41.80B | $42.93B | $42.30B | $39.78B |
| Total Debt | $219.10B | $182.90B | $182.33B | $206.75B | $166.26B | $133.23B | $136.22B | $126.11B | $150.12B | $94.91B | $94.90B | $94.89B | $89.92B | $89.91B | $92.68B | $89.89B | $89.88B | $89.88B | $89.95B | $89.94B |
| Net Debt | $-72.16B | $-85.71B | $-121.60B | $-97.93B | $-118.53B | $-148.22B | $-133.09B | $-141.25B | $-117.88B | $-169.62B | $-192.91B | $-214.74B | $-168.50B | $-193.09B | $-120.40B | $-158.85B | $-103.89B | $-138.14B | $-136.36B | $-164.31B |
Annual Cash Flow
| Breakdown | March 31, 2024 | March 31, 2023 | March 31, 2022 | March 31, 2021 | March 31, 2020 |
|---|---|---|---|---|---|
| Net Income | $61.82B | $45.01B | $54.46B | $52.55B | $128.06B |
| Depreciation and Amortization | $39.40B | $39.98B | $38.40B | $36.30B | $33.70B |
| Deferred Income Tax | $- | $- | $- | $- | $- |
| Stock Based Compensation | $- | $- | $- | $- | $- |
| Change in Working Capital | $-16.18B | $-61.51B | $34.13B | $264.00M | $-43.93B |
| Accounts Receivables | $- | $37.39B | $-40.14B | $25.65B | $-35.17B |
| Inventory | $- | $-36.88B | $-6.34B | $-13.98B | $-2.37B |
| Accounts Payables | $- | $- | $1.03B | $-1.37B | $335.00M |
| Other Working Capital | $-16.18B | $-62.02B | $79.58B | $-10.03B | $-6.72B |
| Other Non Cash Items | $-29.05B | $-25.25B | $-9.40B | $-15.26B | $-15.05B |
| Net Cash Provided by Operating Activities | $55.99B | $-1.77B | $117.59B | $73.85B | $102.78B |
| Investments in Property Plant and Equipment | $-14.32B | $-34.56B | $-40.47B | $-38.14B | $-50.23B |
| Acquisitions Net | $- | $5.21B | $-1.22B | $-227.00M | $5.83B |
| Purchases of Investments | $-6.50B | $-3.70B | $-3.13B | $-2.65B | $-2.15B |
| Sales Maturities of Investments | $3.88B | $10.05B | $2.49B | $3.75B | $13.04B |
| Other Investing Activities | $-8.39B | $281.00M | $13.48B | $404.00M | $5.88B |
| Net Cash Used for Investing Activities | $-25.32B | $-22.72B | $-28.85B | $-36.87B | $-27.62B |
| Debt Repayment | $33.26B | $31.17B | $4.87B | $-82.00M | $-49.00B |
| Common Stock Issued | $- | $- | $- | $- | $- |
| Common Stock Repurchased | $- | $- | $- | $- | $- |
| Dividends Paid | $-45.91B | $-45.89B | $-45.88B | $-45.87B | $-45.85B |
| Other Financing Activities | $-10.06B | $-9.80B | $-7.96B | $-9.96B | $-8.68B |
| Net Cash Used Provided by Financing Activities | $-22.72B | $-24.52B | $-48.97B | $-55.91B | $-103.53B |
| Effect of Forex Changes on Cash | $29.38B | $6.74B | $21.12B | $13.42B | $-9.31B |
| Net Change in Cash | $37.33B | $-42.28B | $60.89B | $-5.50B | $-37.68B |
| Cash at End of Period | $304.68B | $267.35B | $309.63B | $248.74B | $254.24B |
| Cash at Beginning of Period | $267.35B | $309.63B | $248.74B | $254.24B | $291.92B |
| Operating Cash Flow | $55.99B | $-1.77B | $117.59B | $73.85B | $102.78B |
| Capital Expenditure | $-24.82B | $-34.56B | $-40.47B | $-38.14B | $-50.23B |
| Free Cash Flow | $31.17B | $-36.33B | $77.12B | $35.71B | $52.56B |
Cash Flow Charts
| Breakdown | December 31, 2024 | September 30, 2024 | June 30, 2024 | March 31, 2024 | December 31, 2023 | September 30, 2023 | June 30, 2023 | March 31, 2023 | December 31, 2022 | September 30, 2022 | June 30, 2022 | March 31, 2022 | December 31, 2021 | September 30, 2021 | June 30, 2021 | March 31, 2021 | December 31, 2020 | September 30, 2020 | June 30, 2020 | March 31, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | $23.79B | $11.11B | $10.58B | $13.31B | $8.03B | $7.37B | $28.29B | $27.42B | $9.46B | $-1.59B | $9.72B | $-20.78B | $13.89B | $5.56B | $55.78B | $-5.80B | $23.92B | $1.98B | $32.45B | $52.25B |
| Depreciation and Amortization | $10.04B | $9.97B | $10.06B | $9.98B | $9.89B | $9.77B | $9.76B | $10.13B | $10.15B | $9.89B | $9.80B | $9.21B | $9.89B | $9.85B | $9.46B | $9.47B | $9.17B | $8.98B | $8.68B | $8.57B |
| Deferred Income Tax | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Stock Based Compensation | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Change in Working Capital | $-33.63B | $-14.77B | $-24.86B | $-10.60B | $-7.08B | $1.47B | $-22.35B | $-6.71B | $-28.21B | $-25.53B | $-1.06B | $47.34B | $-17.20B | $67.31B | $-63.32B | $48.55B | $-23.16B | $-2.24B | $-22.89B | $9.53B |
| Accounts Receivables | $- | $- | $- | $1.50B | $- | $- | $- | $37.39B | $- | $- | $- | $-40.14B | $- | $- | $- | $25.65B | $- | $- | $- | $-35.17B |
| Inventory | $- | $- | $- | $-21.72B | $- | $- | $- | $-36.88B | $- | $- | $- | $-6.34B | $- | $- | $- | $-13.98B | $- | $- | $- | $-2.37B |
| Accounts Payables | $- | $- | $- | $- | $- | $- | $- | $4.89B | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Other Working Capital | $-33.63B | $-14.77B | $-24.86B | $-10.60B | $-7.08B | $1.47B | $-22.35B | $-12.10B | $-28.21B | $-25.53B | $-1.06B | $93.82B | $-18.12B | $67.31B | $-63.32B | $41.17B | $-23.16B | $-2.24B | $-22.89B | $46.73B |
| Other Non Cash Items | $-281.00M | $3.14B | $-4.36B | $25.33B | $-2.17B | $-1.99B | $-3.05B | $-6.86B | $1.68B | $-5.56B | $-14.52B | $8.64B | $-1.82B | $-37.00M | $-16.19B | $-466.00M | $-6.48B | $-124.00M | $-8.20B | $3.21B |
| Net Cash Provided by Operating Activities | $-84.00M | $9.46B | $-8.58B | $18.06B | $8.67B | $16.62B | $12.64B | $23.99B | $-6.92B | $-22.79B | $3.94B | $44.41B | $4.76B | $82.69B | $-14.27B | $51.75B | $3.46B | $8.60B | $10.05B | $73.56B |
| Investments in Property Plant and Equipment | $-2.83B | $-2.22B | $-3.60B | $5.21B | $-7.60B | $-3.36B | $-8.57B | $-6.70B | $-7.14B | $-4.83B | $-15.89B | $-7.93B | $-10.59B | $-7.07B | $-14.88B | $-7.27B | $-14.19B | $-4.61B | $-12.08B | $-12.44B |
| Acquisitions Net | $- | $-260.00M | $- | $1.60B | $-5.75B | $-874.00M | $-1.58B | $1.68B | $-1.67B | $-2.14B | $-4.06B | $-2.00B | $-6.81B | $-927.00M | $10.53B | $-2.57B | $-12.78B | $-615.00M | $-3.22B | $-2.11B |
| Purchases of Investments | $- | $- | $- | $-1.18B | $-622.00M | $-1.26B | $-3.43B | $-1.11B | $-684.00M | $-1.01B | $-889.00M | $-1.31B | $-294.00M | $-1.05B | $-477.00M | $-1.20B | $-484.00M | $-356.00M | $-611.00M | $-793.00M |
| Sales Maturities of Investments | $- | $- | $- | $1.81B | $1.51B | $234.00M | $331.00M | $213.00M | $3.98B | $5.85B | $4.00M | $47.00M | $181.00M | $33.00M | $2.23B | $2.40B | $1.21B | $28.00M | $112.00M | $7.21B |
| Other Investing Activities | $3.29B | $-324.00M | $7.18B | $90.00M | $6.05B | $922.00M | $1.65B | $3.38B | $1.74B | $2.57B | $4.00B | $1.01B | $-6.83B | $-920.00M | $2.72B | $2.84B | $12.59B | $638.00M | $3.30B | $6.97B |
| Net Cash Used for Investing Activities | $461.00M | $-2.80B | $3.58B | $-2.98B | $-6.40B | $-4.34B | $-11.60B | $-2.54B | $-3.77B | $424.00M | $-16.83B | $-10.19B | $-10.71B | $-8.08B | $124.00M | $-5.81B | $-13.65B | $-4.92B | $-12.50B | $-1.17B |
| Debt Repayment | $-7.54B | $2.51B | $22.52B | $-6.87B | $33.02B | $-3.00B | $10.10B | $-24.02B | $55.20B | $-1.00M | $-1.00M | $- | $- | $-2.78B | $2.78B | $- | $- | $- | $- | $-24.00B |
| Common Stock Issued | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Common Stock Repurchased | $-980.00M | $-20.64B | $-8.48B | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Dividends Paid | $-22.58B | $- | $-22.96B | $- | $-22.96B | $- | $-22.95B | $- | $-22.95B | $- | $-22.94B | $- | $-22.94B | $- | $-22.94B | $- | $-22.93B | $- | $-22.93B | $- |
| Other Financing Activities | $40.00B | $-3.10B | $-2.97B | $-2.47B | $-2.46B | $-2.52B | $-2.61B | $-2.42B | $-2.53B | $-2.56B | $-2.30B | $4.48B | $-2.56B | $-2.63B | $-2.38B | $-2.27B | $-2.45B | $-2.86B | $-2.46B | $-1.97B |
| Net Cash Used Provided by Financing Activities | $8.90B | $-21.24B | $-11.89B | $-9.34B | $7.60B | $-5.52B | $-15.46B | $-26.44B | $29.72B | $-2.56B | $-25.24B | $4.48B | $-25.50B | $-5.41B | $-22.53B | $-2.27B | $-25.39B | $-2.86B | $-25.39B | $-25.97B |
| Effect of Forex Changes on Cash | $13.37B | $-20.75B | $16.14B | $14.15B | $-6.53B | $5.38B | $16.37B | $4.34B | $-15.55B | $1.64B | $16.31B | $12.51B | $6.86B | $724.00M | $1.02B | $11.29B | $1.34B | $886.00M | $-97.00M | $-4.71B |
| Net Change in Cash | $291.26B | $-303.94B | $303.94B | $19.89B | $3.34B | $12.15B | $1.96B | $-652.00M | $3.48B | $-23.29B | $-21.82B | $51.21B | $-24.58B | $69.92B | $-35.66B | $54.96B | $-34.24B | $1.71B | $-27.94B | $41.71B |
| Cash at End of Period | $291.26B | $- | $303.94B | $304.68B | $284.79B | $281.45B | $269.31B | $267.35B | $268.00B | $264.53B | $287.81B | $309.63B | $258.42B | $283.00B | $213.08B | $248.74B | $193.78B | $228.02B | $226.31B | $254.24B |
| Cash at Beginning of Period | $- | $303.94B | $- | $284.79B | $281.45B | $269.31B | $267.35B | $268.00B | $264.53B | $287.81B | $309.63B | $258.42B | $283.00B | $213.08B | $248.74B | $193.78B | $228.02B | $226.31B | $254.24B | $212.53B |
| Operating Cash Flow | $-84.00M | $9.46B | $-8.58B | $18.06B | $8.67B | $16.62B | $12.64B | $23.99B | $-6.92B | $-22.79B | $3.94B | $44.41B | $4.76B | $82.69B | $-14.27B | $51.75B | $3.46B | $8.60B | $10.05B | $73.56B |
| Capital Expenditure | $-2.83B | $-2.22B | $-3.60B | $5.21B | $-7.60B | $-3.36B | $-8.57B | $-6.70B | $-7.14B | $-4.83B | $-15.89B | $-7.93B | $-10.59B | $-7.07B | $-14.88B | $-7.27B | $-14.19B | $-4.61B | $-12.08B | $-12.44B |
| Free Cash Flow | $-2.92B | $7.24B | $-12.18B | $23.27B | $1.07B | $13.26B | $4.07B | $17.29B | $-14.06B | $-27.62B | $-11.94B | $36.48B | $-5.82B | $75.62B | $-29.15B | $44.48B | $-10.74B | $3.99B | $-2.03B | $61.12B |
Eisai Dividends
Explore Eisai 's dividend history, including dividend yield, payout ratio, and historical payments.
Dividend Yield
2.63%
Dividend Payout Ratio
108.27%
Dividend Paid & Capex Coverage Ratio
0.79x
Eisai Dividend History
| Dividend | Adjusted Dividend | Date | Record Date | Payment Date | Declaration Date |
|---|---|---|---|---|---|
| $80 | $80 | March 28, 2025 | March 31, 2025 | May 01, 2025 | |
| $80 | $80 | September 27, 2024 | September 30, 2024 | November 19, 2024 | |
| $80 | $80 | March 28, 2024 | March 31, 2024 | May 29, 2024 | |
| $80 | $80 | September 28, 2023 | September 30, 2023 | November 17, 2023 | |
| $80 | $80 | March 30, 2023 | March 31, 2023 | May 29, 2023 | |
| $80 | $80 | September 29, 2022 | September 30, 2022 | November 18, 2022 | |
| $80 | $80 | March 30, 2022 | March 31, 2022 | May 25, 2022 | |
| $80 | $80 | September 29, 2021 | September 30, 2021 | November 19, 2021 | |
| $80 | $80 | March 30, 2021 | March 31, 2021 | May 21, 2021 | |
| $80 | $80 | September 29, 2020 | September 30, 2020 | November 19, 2020 | |
| $80 | $80 | March 30, 2020 | March 31, 2020 | May 22, 2020 | |
| $80 | $80 | September 27, 2019 | September 30, 2019 | November 19, 2019 | |
| $80 | $80 | March 27, 2019 | March 31, 2019 | May 22, 2019 | |
| $70 | $70 | September 26, 2018 | September 30, 2018 | November 19, 2018 | |
| $80 | $80 | March 28, 2018 | March 31, 2018 | May 24, 2018 | |
| $70 | $70 | September 27, 2017 | September 30, 2017 | November 17, 2017 | |
| $80 | $80 | March 29, 2017 | March 31, 2017 | May 19, 2017 | |
| $70 | $70 | September 28, 2016 | |||
| $80 | $80 | March 29, 2016 | |||
| $70 | $70 | September 28, 2015 |
Eisai News
Read the latest news about Eisai , including recent articles, headlines, and updates.
Similar Companies
Related Metrics
Explore detailed financial metrics and analysis for 4523.T.